Clinical Trial Update: Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial [Phase 4]

View source ↗

Summary

This document notes the MOVE-JIA trial (Phase 4) at Oslo University Hospital pursuing optimization of treatment for Juvenile Idiopathic Arthritis in sustained r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: Oslo University Hospital | Conditions: Juvenile Idiopathic Arthritis | Phase 4 | Status: RECRUITING